# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The delivery specialist has seen a boost in efficiency and found immediate cost savings from deploying NICE CXoneNICE (NASDAQ:N...
Wedbush analyst Daniel Ives reiterates NICE (NASDAQ:NICE) with a Outperform and maintains $250 price target.
RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and raises the price target from $230 to $260.
JMP Securities analyst Patrick Walravens reiterates NICE (NASDAQ:NICE) with a Market Outperform and maintains $300 price tar...
Northland Capital Markets analyst Michael Latimore maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price targe...
Rosenblatt analyst Catharine Trebnick maintains NICE (NASDAQ:NICE) with a Buy and maintains $225 price target.
Full-Year 2024:Full-year 2024 non-GAAP total revenues are expected to be in a range of $2,715 million to $2,735 million, repres...
Third-Quarter 2024:Third-quarter 2024 non-GAAP total revenues are expected to be in a range of $676 million to $686 million, re...